#  Toker lab identifies metabolic vulnerability in TNBC 

 





March 02, 2017

 

 

Ludwig researchers have shown that triple-negative breast cancer cells ramp up production of a key component of DNA in response to chemotherapy and that targeting this pathway could undermine their resistance to such therapies.

Coverge from Ludwig Cancer Research [here](http://tinyurl.com/jau8vps).

Cancer Discovery publication [here](http://tinyurl.com/h95r85g).



 

 

 



 

 

 Share on:- [     Facebook ](#)
- [     Twitter ](#)
- [     Linkedin ](#)